Quan Vu

Quan Vu

Chief Financial Officer, Secretary, and TreasureratMonopar Therapeutics· In proxies 2024–2025

Pay in FY2025Monopar Therapeutics stock +196.8% the same year

Quan Vu was paid $2.1M in FY2025 (Dec). Monopar Therapeutics stock rose 196.8% that year.

Pay$100 in the stock at the end of FY23 → $3.8K
Pay is from the Summary Compensation Table of each Monopar Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Monopar TherapeuticsPublic company · 2 yr
    • Chief Financial Officer, Secretary, and Treasurer2024 – Present · 2 yrStock in role +3,721%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?